BioSpace News Archive

For the IMerge Phase 2 clinical trial, meaningful and durable transfusion independence reported with a new 1-year TI rate, indicating potential disease-modifying activity of imetelstat treatment For the IMbark Phase 2 clinical trial, the analyses correlate the potential improvement in overall survival from imetelstat treatment with other clinical benefits observed in the trial, such as fibrosis improvement, as well as symptom and spleen response Data provide further support of ongoing and pla

(“LivaNova”) today announced the pricing of $250 million aggregate principal amount of 3.00% cash exchangeable senior notes due 2025 to be issued by its wholly owned U.S. subsidiary, LivaNova USA, Inc., in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In addition, LivaNova has granted the initial purchasers of the notes an option

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 3,883,036 common shares at a purchase price of US$2.97375 per common share in a registered direct offering (the “Offering”) priced at-the-market under Nasdaq rules for aggregate gross proceeds to the Company of

As facilities and establishments continue to open across the country, there will be no returning to “normal”. COVID-19 has altered our standards for health and safety and with that, procedures have been put in place specific to each industry.

Ayin Health Solutions (Ayin), the national population health management company of Providence St. Joseph Health, announced today that its chief executive officer, Rhonda Medows , MD, FAAFP has been named as chairperson-elect of the Board of Trustees for the Catholic Health Association of the United States (CHA) for fiscal year 2021

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 386 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2020, to shareholders of record at the close of business on July 15, 2020 . Abbott has inc

Oceans Healthcare and the Massachusetts General Hospital Department of Psychiatry have signed an agreement that will give patients of the behavioral health network access to some of the world’s most highly qualified psychiatrists.

Q BioMed (OTC: QBIO) is proud to be a Supporter of the Living Beyond Breast Cancer (LBBC) 2020 Virtual Conference on Metastatic Breast Cancer taking place June 13 and 14, 2020.

Cancers cells use a special technique to propagate; they delete their “programmed death” gene through mutation, “forget” to die when their lifetime is over, and continue to grow instead

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, announced today that Robert Winn, MD, Director, Virginia Commonwealth University Massey Cancer Center, joined LUNGevity’s Board of Directors.